These results are in agreement with other studies showing increased concentrations of TIMP-1 during the acute phase of ICH, that remained highly sustained during the first week after stroke onset23, and showing TIMP-1 association with early mortality rates24, supporting a potential role of TIMP-1 as severity biomarker in ICH. This evidence concerns the gene TIMP1 and stroke disorder.